Astragalus
Astragalus is a traditional medicinal herb derived from the root of Astragalus membranaceus, used for its immunomodulatory, adaptogenic, and cardioprotective properties.
Overview
Astragalus membranaceus (also known as Huang Qi) is one of the most widely used herbs in traditional Chinese medicine, with a documented history spanning over two thousand years. The root contains a complex array of bioactive compounds including polysaccharides, saponins (such as astragalosides), and flavonoids, which collectively contribute to its pharmacological profile. It is traditionally classified as a qi-tonifying herb and has been used to support immune function, energy, and overall vitality.
Modern research has focused on the immunomodulatory effects of astragalus, with studies indicating it can enhance natural killer cell activity, stimulate macrophage function, and promote T-cell proliferation. Clinical investigations have explored its potential as an adjunctive therapy in cancer treatment, where it may help mitigate chemotherapy-induced immunosuppression. The herb has also been studied for cardioprotective effects, including improvement of left ventricular function in patients with heart failure, and for renoprotective activity in the context of diabetic nephropathy.
Astragalus root preparations are available in numerous forms including dried root slices, powdered extracts, and standardized capsules. It is generally considered safe, though it may interact with immunosuppressive medications due to its immune-stimulating properties. Quality and potency can vary significantly among commercial products, making standardized extracts preferable for research and therapeutic applications.
Mechanism of Action
Multi-Component Pharmacology
Astragalus (Astragalus membranaceus) root contains three principal bioactive classes: astragalosides (cycloartane triterpenoid saponins, especially astragaloside IV), astragalus polysaccharides (APS, heteroglycans), and isoflavonoids (formononetin, calycosin). These constituents act synergistically across immune, cardiovascular, and metabolic pathways (PMID: 22981502).
Immune System Enhancement
Astragalus polysaccharides bind to Toll-like receptor 4 (TLR4) on macrophages and dendritic cells, activating the MyD88/NF-kB and MAPK signaling cascades. This stimulates phagocytosis, antigen presentation, and secretion of IL-2, IL-12, and IFN-gamma — shifting immunity toward a Th1 response. APS also promotes T cell proliferation and enhances NK cell cytotoxicity through upregulation of NKG2D and perforin expression (PMID: 20041385).
Telomere Protection & Anti-Aging
Astragaloside IV activates telomerase (hTERT) expression via MAPK/ERK signaling, supporting telomere length maintenance in lymphocytes and stem cells. Cycloastragenol, a sapogenin metabolite, has been commercialized as the telomerase activator TA-65. This mechanism extends immune cell replicative capacity and may slow immunosenescence (PMID: 21426483).
Cardiovascular & Cardioprotective Mechanisms
Astragaloside IV activates PI3K/Akt and eNOS pathways, enhancing nitric oxide production and vasodilation. It protects cardiomyocytes from ischemia-reperfusion injury by stabilizing mitochondrial membrane potential, reducing caspase activation, and upregulating Bcl-2/Bax ratio. Formononetin also activates PPAR-gamma, improving lipid metabolism (PMID: 27174435).
Nrf2 Antioxidant & Anti-Fibrotic Effects
Astragalus components activate Keap1-Nrf2-ARE signaling, upregulating HO-1, SOD, and GPx. Astragaloside IV inhibits TGF-beta1/Smad signaling, reducing collagen deposition and myofibroblast activation — mechanisms investigated for renal and pulmonary fibrosis (PMID: 25267474).
Reconstitution Calculator
Research
Reported Effects
Subtle Effects:: Most users report mild, gradual benefits rather than immediate or dramatic changes, leading some to question its value. Synergistic Use:: Appears most effective when combined with other supplements (quercetin, adaptogens, rhodiola) rather than standalone. Individual Variation:: Effectiveness varies considerably between users, with some reporting no noticeable benefits even after months of use. Bioavailability Enhancement:: Research suggests Astragalus polysaccharides may enhance absorption of other compounds like quercetin by 68-fold
- Most users report mild, gradual benefits rather than immediate or dramatic changes, leading some to question its value
- Appears most effective when combined with other supplements (quercetin, adaptogens, rhodiola) rather than standalone
- Effectiveness varies considerably between users, with some reporting no noticeable benefits even after months of use
- Research suggests Astragalus polysaccharides may enhance absorption of other compounds like quercetin by 68-fold
Renal protection in kidney disease
Astragalus membranaceus, a traditional Chinese medicinal herb rich in astragaloside IV and polysaccharides, is widely studied as an add-on for chronic and diabetic kidney disease. Randomized trials and Cochrane reviews suggest reductions in proteinuria and modest renal benefit, though evidence quality is limited by small, largely Chinese studies; the multi-center 2024 RCT and the READY protocol aim to strengthen the evidence base.
- Add-on astragalus studied for reduced albuminuria in diabetic CKD
- Cochrane review found possible renal benefit but low-quality evidence
- Larger rigorous RCTs (2024 multi-center, READY) underway or reported
Immune modulation and oncology support
Astragalus polysaccharides modulate innate and adaptive immunity and are used as chemotherapy adjuncts. Meta-analyses of astragalus-containing regimens report improved quality of life, immune parameters, and tumor response when combined with platinum-based chemotherapy in lung and other cancers.
- Improved quality of life with platinum chemotherapy in NSCLC
- Enhances immune cell parameters in clinical and preclinical studies
- Meta-analyses suggest reduced chemotherapy toxicity
Safety Profile
Safety Profile: Astragalus (Astragalus membranaceus / Huang Qi)
Common Side Effects
- Mild gastrointestinal symptoms: bloating, loose stools, diarrhea (dose-related)
- Mild allergic reactions: skin rash, itching
- Dizziness and fatigue at higher doses
- Nasal dryness with prolonged use (traditional Chinese medicine observation)
- Mild diuretic effect (increased urination)
Serious Adverse Effects
- Immune overstimulation: Astragalus polysaccharides and saponins (astragalosides) are potent immunomodulators. May exacerbate autoimmune conditions including lupus, rheumatoid arthritis, multiple sclerosis, and Crohn's disease
- Potential interference with immunosuppressive therapy; documented reduction in cyclosporine efficacy in animal models
- Hypoglycemia: Astragalus has demonstrated blood glucose-lowering effects in diabetic models; risk of hypoglycemia with concurrent antidiabetic therapy
- Bleeding: Astragaloside IV has antiplatelet properties; may increase bleeding risk
- Herb-contamination risk: Some Astragalus species (A. lentiginosus, A. mollissimus) are toxic selenium accumulators ("locoweed"); quality sourcing critical
- Potential drug-herb interactions with transplant immunosuppression (see below)
Contraindications
- Active autoimmune diseases (SLE, RA, MS, IBD, Type 1 diabetes) unless under direct medical supervision
- Organ transplant recipients on immunosuppressive regimens
- Known allergy to Astragalus or Fabaceae (legume) family plants
- Acute infection with fever (traditional Chinese medicine contraindication; may "trap" pathogen)
- Active bleeding or hemorrhagic conditions
- Pre-surgery: Discontinue at least 2 weeks before scheduled procedures
Drug Interactions
- Immunosuppressants (cyclosporine, tacrolimus, mycophenolate, azathioprine): Astragalus may directly counteract immunosuppression; potentially dangerous in transplant patients. Well-documented in pharmacological studies
- Anticoagulants/Antiplatelets (warfarin, heparin, clopidogrel, aspirin): Additive bleeding risk; monitor INR with warfarin
- Antidiabetic medications (insulin, metformin, sulfonylureas): Enhanced hypoglycemic effect; glucose monitoring required
- Lithium: Diuretic properties of astragalus may reduce lithium clearance, increasing levels and toxicity risk
- Antihypertensives: Mild blood pressure-lowering effect may be additive
- Cyclophosphamide: Complex interaction; astragalus may reduce cyclophosphamide-induced immunosuppression (studied in oncology settings)
- CYP substrates: Limited CYP interaction data; some in vitro inhibition of CYP2C19 reported
Population-Specific Considerations
- Pregnancy: Traditionally used in Chinese medicine during pregnancy for "Qi deficiency," but modern safety data insufficient. Some animal studies suggest uterotonic effects. European and American guidelines recommend avoiding during pregnancy. Not recommended during breastfeeding without medical supervision
- Pediatric: Used traditionally in children for immune support in Chinese medicine. Limited Western clinical trial data in pediatric populations. Standard doses (3-5 mg/kg) generally well tolerated in children >6 years in small studies. Avoid in children with autoimmune conditions
- Elderly: Generally well tolerated and potentially beneficial for age-related immune decline. Clinical trials in elderly populations (cardiovascular protection) have shown acceptable safety profiles. Adjust dose for renal impairment. Monitor for drug interactions with cardiovascular and diabetic medications
Pharmacokinetic Profile
Astragalus — Pharmacokinetic Curve
SubcutaneousQuick Start
- Typical Dose
- 550-1000mg daily is commonly used, often from root extract capsules
Research Indications
Renal
Add-on astragalus studied for reducing albuminuria and slowing decline in diabetic and chronic kidney disease.
Oncology Supportive Care
Astragalus/astragalus polysaccharide combined with platinum-based chemotherapy improved quality of life and may reduce toxicity in NSCLC.
Immune and General
Astragalus polysaccharides enhance immune parameters in preclinical and small clinical studies.
Safety Profile
Common Side Effects
- Generally Well-Tolerated:: Most users report no significant side effects, making it one of the safer herbs in supplement stacks
- Mild GI Effects:: Some reports of mild gastrointestinal irritation when taken on empty stomach or at higher doses
- Quality Concerns:: Users note that cheaper brands may contain contaminants or inactive ingredients, emphasizing need for reputable sources
- Minimal Interactions:: Few reported interactions with other supplements, though careful stacking still recommended
References (12)
- [6]Astragalus polysaccharide alleviates mastitis disrupted by Staphylococcus aureus infection by regulating gut microbiota and SCFAs metabolism
→ APS treatment reduced inflammation and oxidative stress while protecting tissue barriers during bacterial infection by regulating gut microbiota and short-chain fatty acid metabolism, highlighting systemic immune benefits through gut modulation.
- [1]A Natural Astragalus-Based Nutritional Supplement Lengthens Telomeres in a Middle-Aged Population: A Randomized, Double-Blind, Placebo-Controlled Study
→ A 6-month randomized controlled trial found that Astragalus-based supplementation significantly lengthened telomeres in healthy middle-aged adults (mean age 56.1 years), suggesting potential anti-aging effects through genomic integrity maintenance.
- [2]Structural characterization and anti-inflammatory activity of polysaccharides from Astragalus membranaceus
→ Research identified two distinct polysaccharides (APS-A1 and APS-B1) from Astragalus with characterized molecular structures and demonstrated anti-inflammatory properties, providing mechanistic understanding of its therapeutic effects.
- [3]Effects of Dietary Astragalus Polysaccharide Supplementation on the Th17/Treg Balance and the Gut Microbiota of Broiler Chickens Challenged With Necrotic Enteritis
→ Astragalus polysaccharide (200 ppm) supplementation improved immune balance, reduced inflammatory markers, and modulated gut microbiota composition in an infection challenge model, demonstrating immunomodulatory and gut health benefits.
- [4]Astragalus polysaccharide (APS) supplement in beagle dogs after castration: Effects on the haematology and serum chemistry profiles, immune response, and oxidative stress status
→ An 8-week study with APS supplementation (400-800 mg/kg) showed improvements in hematology profiles, immune response markers, and oxidative stress status in dogs post-surgery, supporting its role in enhancing natural defense mechanisms.
- [7]Desulfovibrio vulgaris, a potent acetic acid-producing bacterium, attenuates nonalcoholic fatty liver disease in mice
→ Study demonstrated that Astragalus-derived polysaccharides can modulate specific gut bacteria to produce beneficial metabolites, showing therapeutic potential for metabolic conditions like NAFLD through microbiome regulation.
- [8]Astragalus species: Insights on its chemical composition toward pharmacological applications
→ Comprehensive review detailing the chemical composition of Astragalus species including polysaccharides, saponins, and flavonoids, providing scientific basis for its diverse pharmacological applications in traditional and modern medicine.
- [5]Oral Astragalus polysaccharide alleviates adenine-induced kidney injury by regulating gut microbiota-short-chain fatty acids-kidney G protein-coupled receptors axis
→ Astragalus polysaccharide protected against chronic kidney disease by modulating gut microbiota composition, increasing beneficial bacteria and short-chain fatty acid production, demonstrating a gut-kidney axis mechanism of action.
- [9]et al. Add-on astragalus in type 2 diabetes and chronic kidney disease: A multi-center, assessor-blind, randomized controlled trial Phytomedicine (2024)
→ Add-on astragalus in type 2 diabetes with CKD was evaluated for effects on albuminuria and renal function in a multi-center RCT.
- [10]Guo L, Bai SP, Zhao L, Wang XH Astragalus polysaccharide injection integrated with vinorelbine and cisplatin for patients with advanced non-small cell lung cancer Medical Oncology (2012)
→ Astragalus polysaccharide added to chemotherapy improved quality of life in advanced NSCLC.
- [11]Zou YH, Liu XM Effect of astragalus injection combined with chemotherapy on quality of life in patients with advanced non-small cell lung cancer Zhongguo Zhong Xi Yi Jie He Za Zhi (2003)
→ Astragalus injection with chemotherapy improved quality-of-life measures in advanced NSCLC.
- [12]et al. Efficacy, safety and response predictors of adjuvant astragalus for diabetic kidney disease (READY): study protocol of a randomised controlled trial BMJ Open (2021)
→ Protocol for a pragmatic RCT of add-on astragalus for diabetic kidney disease with macroalbuminuria.
Astragaloside IV
Astragaloside IV (AS-IV) is a cycloartane-type triterpene saponin extracted from Astragalus membranaceus, a traditional Chinese medicinal herb. It works through
Astragalus Polysaccharides
Astragalus polysaccharides (APS) are bioactive compounds extracted from Astragalus membranaceus, a traditional Chinese medicinal herb. These complex carbohydrat